v3.25.1
STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net Loss $ (6,365,984) $ (4,343,104)
Adjustments to reconcile net income (loss) to net cash from operating activities:    
Change in fair value of derivatives (161,122) (88,880)
Loss on issuance of derivatives 191,162 130,305
Loss on impairment of assets 957,377 0
Gain on extinguishment of debt (264,539) (49,248)
Change in fair value of contingent liability 0 (450)
Shares issued for services 267,500 1,951,346
Warrants issued for services 53,991 301,090
Options issued for services 0 27,962
Amortization of debt discount 294,222 161,932
Depreciation expense and amortization 112,850 67,950
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 395,737 (100,045)
Contingent liabilities 437,500 0
Accounts payable 222,587 6,942
Accrued interest 361,979 117,727
Net cash from operating activities (3,496,740) (1,816,473)
Cash flows from investing activities:    
Purchase of property and equipment (338,001) (387,682)
Issuance of loan receivable (90,000) (100,000)
Noncontrolling interest contribution 120,000 0
Net cash from investing activities (308,001) (487,682)
Cash flows from financing activities:    
Repayment of notes payable - related parties 0 (25,000)
Repayment of notes payable (95,000) (908,501)
Repayment of convertible notes payable (277,638) (380,250)
Proceeds from convertible notes payable 2,582,650 3,971,500
Proceeds from notes payable 183,061 340,074
Proceeds from the sale of common stock 150,000 0
Net cash from financing activities 2,543,073 2,997,823
Net change in cash and cash equivalents from continuing operations (1,261,668) 693,668
 Net change in operating activities from discontinued operations 1,301,882 216,993
 Net change in investing activities from discontinued operations (220,220) (968,593)
 Net change in financing activities from discontinued operations 0 0
Net change in cash and cash equivalents from discontinued operations 1,081,662 (751,600)
Net change in cash and cash equivalents (180,006) (57,932)
Cash and cash equivalents at beginning of year 239,417 297,349
Cash and cash equivalents at end of period 59,411 239,417
Cash and cash equivalents paid during the period for:    
Interest 0 0
Income taxes 0 0
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Shares issued for conversion of convertible notes payable and accrued interest 1,695,000 1,167,000
Shares issued for notes payable 0 50,000
Shares issued for contingent liability 0 5,250
Purchase of intangible assets with debt 0 758,501
Purchase of intangible assets with stock 0 370,000
Conversion of common stock to preferred stock 0 50,000
Debt discount on convertible notes payable 337,889 225,000
Conversion of related party notes payable to common stock 0 3,000
Shares issued for accrued interest $ 253,842 $ 28,593